Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAH
Crossref DOI link: https://doi.org/10.1186/s12931-016-0388-6
Published Online: 2016-06-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McCollister, Deborah
Shaffer, Shannon
Badesch, David B.
Filusch, Arthur
Hunsche, Elke
Schüler, René
Wiklund, Ingela
Peacock, Andrew
Funding for this research was provided by:
Actelion Pharmaceuticals (NA)